These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year follow-up: A systematic review and meta-analysis of studies. Mukete BN; van der Heijden LC; Tandjung K; Baydoun H; Yadav K; Saleh QA; Doggen CJ; Abi Rafeh N; Le Jemtel TH; von Birgelen C Int J Cardiol; 2016 Oct; 221():1087-94. PubMed ID: 27448538 [TBL] [Abstract][Full Text] [Related]
43. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries. Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648 [TBL] [Abstract][Full Text] [Related]
44. The coronary resorbable magnesium scaffold Magmaris®: what we have learnt (so far…). Bennett J; McCUTCHEON K Minerva Cardiol Angiol; 2021 Apr; 69(2):215-221. PubMed ID: 32326679 [TBL] [Abstract][Full Text] [Related]
45. Strut protrusion and shape impact on endothelial shear stress: insights from pre-clinical study comparing Mirage and Absorb bioresorbable scaffolds. Tenekecioglu E; Sotomi Y; Torii R; Bourantas C; Miyazaki Y; Collet C; Crake T; Su S; Onuma Y; Serruys PW Int J Cardiovasc Imaging; 2017 Sep; 33(9):1313-1322. PubMed ID: 28365819 [TBL] [Abstract][Full Text] [Related]
46. Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial. von Birgelen C; Zocca P; Buiten RA; Jessurun GAJ; Schotborgh CE; Roguin A; Danse PW; Benit E; Aminian A; van Houwelingen KG; Anthonio RL; Stoel MG; Somi S; Hartmann M; Linssen GCM; Doggen CJM; Kok MM Lancet; 2018 Oct; 392(10154):1235-1245. PubMed ID: 30253879 [TBL] [Abstract][Full Text] [Related]
47. In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial. Okamura T; Garg S; Gutiérrez-Chico JL; Shin ES; Onuma Y; García-García HM; Rapoza RJ; Sudhir K; Regar E; Serruys PW EuroIntervention; 2010 Apr; 5(8):932-8. PubMed ID: 20542778 [TBL] [Abstract][Full Text] [Related]
49. Perioperative Management of Dual-Antiplatelet Therapy in Patients With New-Generation Drug-Eluting Metallic Stents and Bioresorbable Vascular Scaffolds Undergoing Elective Noncardiac Surgery. Essandoh M; Dalia AA; Albaghdadi M; George B; Stoicea N; Shabsigh M; Rao SV J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1857-1864. PubMed ID: 28826683 [TBL] [Abstract][Full Text] [Related]
50. Bioresorbable drug-eluting magnesium-alloy scaffold: design and feasibility in a porcine coronary model. Wittchow E; Adden N; Riedmüller J; Savard C; Waksman R; Braune M EuroIntervention; 2013 Apr; 8(12):1441-50. PubMed ID: 23680959 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436 [TBL] [Abstract][Full Text] [Related]
52. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. Gomez-Lara J; Garcia-Garcia HM; Onuma Y; Garg S; Regar E; De Bruyne B; Windecker S; McClean D; Thuesen L; Dudek D; Koolen J; Whitbourn R; Smits PC; Chevalier B; Dorange C; Veldhof S; Morel MA; de Vries T; Ormiston JA; Serruys PW JACC Cardiovasc Interv; 2010 Nov; 3(11):1190-8. PubMed ID: 21087756 [TBL] [Abstract][Full Text] [Related]
53. Hemocompatibility of plasma electrolytic oxidation (PEO) coated Mg-RE and Mg-Zn-Ca alloys for vascular scaffold applications. Kröger N; Kopp A; Staudt M; Rusu M; Schuh A; Liehn EA Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():819-826. PubMed ID: 30184811 [TBL] [Abstract][Full Text] [Related]
54. An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition). Ormiston JA; Webber B; Ubod B; Darremont O; Webster MW EuroIntervention; 2015 May; 11(1):60-7. PubMed ID: 25680225 [TBL] [Abstract][Full Text] [Related]
55. Absorb Bioresorbable Vascular Scaffold in Complex Coronary Bifurcation Interventions: Insights From an In Vivo Multimodality Imaging Study. Bennett J; Vanhaverbeke M; Vanden Driessche N; Adriaenssens T; Hiltrop N; Desmet W; Sinnaeve P; Dubois C Circ Cardiovasc Interv; 2016 Aug; 9(8):. PubMed ID: 27512090 [TBL] [Abstract][Full Text] [Related]
56. Bioresorbable Scaffolds versus Metallic Stents in Routine PCI. Wykrzykowska JJ; Kraak RP; Hofma SH; van der Schaaf RJ; Arkenbout EK; IJsselmuiden AJ; Elias J; van Dongen IM; Tijssen RYG; Koch KT; Baan J; Vis MM; de Winter RJ; Piek JJ; Tijssen JGP; Henriques JPS; N Engl J Med; 2017 Jun; 376(24):2319-2328. PubMed ID: 28402237 [TBL] [Abstract][Full Text] [Related]
57. Impact of post-dilatation on strut apposition of second-generation bioresorbable vascular scaffolds: Key role for scaffold thrombosis and prognosis? Frangieh AH; Jaguszewski M; Imori Y; Obeid S; Templin C Cardiol J; 2018; 25(1):148-150. PubMed ID: 29512102 [No Abstract] [Full Text] [Related]
58. Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarction: The snowshoe effect: Insights from the maximal footprint analysis. Diletti R; van der Sijde J; Karanasos A; Fam JM; Felix C; van Mieghem NM; Regar E; Rapoza R; Zijlstra F; van Geuns RJ Int J Cardiol; 2016 Oct; 220():802-8. PubMed ID: 27394977 [TBL] [Abstract][Full Text] [Related]
59. Impact of stent surface on thrombogenicity and vascular healing: a comparative analysis of metallic and polymeric surfaces. Eppihimer MJ; Sushkova N; Grimsby JL; Efimova N; Kai W; Larson S; Forsyth B; Huibregtse BA; Dawkins KD; Wilson GJ; Granada JF Circ Cardiovasc Interv; 2013 Aug; 6(4):370-7. PubMed ID: 23899869 [TBL] [Abstract][Full Text] [Related]